Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jennifer H. Y. Lam"'
Autor:
Xiaofeng Mu, Carolyn A. Cohen, Daniel Leung, Jaime S. Rosa Duque, Samuel M. S. Cheng, Yuet Chung, Howard H. W. Wong, Amos M. T. Lee, Wing Yan Li, Issan Y. S. Tam, Jennifer H. Y. Lam, Derek H. L. Lee, Sau Man Chan, Leo C. H. Tsang, Karl C. K. Chan, John K. C. Li, Leo L. H. Luk, Sara Chaothai, Kelvin K. H. Kwan, Nym Coco Chu, Masashi Mori, Trushar Jeevan, Ahmed Kandeil, Richard J. Webby, Wenwei Tu, Sophie A. Valkenburg, Malik Peiris, Yu Lung Lau
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-10 (2022)
Abstract The high effectiveness of the third dose of BNT162b2 in healthy adolescents against Omicron BA.1 has been reported in some studies, but immune responses conferring this protection are not yet elucidated. In this analysis, our study (NCT04800
Externí odkaz:
https://doaj.org/article/cbb87e487bc041848913a814dedbe2d2
Autor:
Jaime S. Rosa Duque, Xiwei Wang, Daniel Leung, Samuel M. S. Cheng, Carolyn A. Cohen, Xiaofeng Mu, Asmaa Hachim, Yanmei Zhang, Sau Man Chan, Sara Chaothai, Kelvin K. H. Kwan, Karl C. K. Chan, John K. C. Li, Leo L. H. Luk, Leo C. H. Tsang, Wilfred H. S. Wong, Cheuk Hei Cheang, Timothy K. Hung, Jennifer H. Y. Lam, Gilbert T. Chua, Winnie W. Y. Tso, Patrick Ip, Masashi Mori, Niloufar Kavian, Wing Hang Leung, Sophie Valkenburg, Malik Peiris, Wenwei Tu, Yu Lung Lau
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
There are adverse events associated with COVID-19 vaccines, such as myocarditis for adolescents following receipt of SARS-CoV-2 mRNA vaccines. Here the authors compare the immunogenicity and reactogenicity of two widely available SARS-CoV-2 vaccines
Externí odkaz:
https://doaj.org/article/f4b9f38e2cf744f5a91a3b8ac36a6c70
Autor:
Daniel Leung, Carolyn A. Cohen, Xiaofeng Mu, Jaime S. Rosa Duque, Samuel M. S. Cheng, Xiwei Wang, Manni Wang, Wenyue Zhang, Yanmei Zhang, Issan Y. S. Tam, Jennifer H. Y. Lam, Sau Man Chan, Sara Chaothai, Kelvin K. H. Kwan, Karl C. K. Chan, John K. C. Li, Leo L. H. Luk, Leo C. H. Tsang, Nym Coco Chu, Wilfred H. S. Wong, Masashi Mori, Wing Hang Leung, Sophie Valkenburg, Malik Peiris, Wenwei Tu, Yu Lung Lau
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionTwo doses of inactivated SARS-CoV-2 vaccine CoronaVac cannot elicit high efficacy against symptomatic COVID-19, especially against the Omicron variant, but that can be improved by a third dose in adults. The use of a third dose of CoronaV
Externí odkaz:
https://doaj.org/article/d01897681a6043d09727b5d24eb8e7ff
Autor:
Daniel Leung, Xiaofeng Mu, Jaime S. Rosa Duque, Samuel M. S. Cheng, Manni Wang, Wenyue Zhang, Yanmei Zhang, Issan Y. S. Tam, Toby S. S. Lee, Jennifer H. Y. Lam, Sau Man Chan, Cheuk Hei Cheang, Yuet Chung, Howard H. W. Wong, Amos M. T. Lee, Wing Yan Li, Sara Chaothai, Leo C. H. Tsang, Gilbert T. Chua, Kai-Ning Cheong, Elaine Y. L. Au, Janette S. Y. Kwok, Koon Wing Chan, Patrick C. Y. Chong, Pamela P. W. Lee, Marco H. K. Ho, Tsz Leung Lee, Wenwei Tu, Malik Peiris, Yu Lung Lau
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Our study (NCT04800133) aimed to determine the safety and immunogenicity in patients with IEIs receiving a 3-dose primary series of mRNA vaccine BNT162b2 (age 12+) or inactivated whole-virion vaccine CoronaVac (age 3+) in Hong Kong, including Omicron
Externí odkaz:
https://doaj.org/article/40439ee79362418ba1ea1faa97dea241
Autor:
Jaime S. Rosa Duque, Xiwei Wang, Daniel Leung, Samuel M. S. Cheng, Carolyn A. Cohen, Xiaofeng Mu, Asmaa Hachim, Yanmei Zhang, Sau Man Chan, Sara Chaothai, Kelvin K. H. Kwan, Karl C. K. Chan, John K. C. Li, Leo L. H. Luk, Leo C. H. Tsang, Wilfred H. S. Wong, Cheuk Hei Cheang, Timothy K. Hung, Jennifer H. Y. Lam, Gilbert T. Chua, Winnie W. Y. Tso, Patrick Ip, Masashi Mori, Niloufar Kavian, Wing Hang Leung, Sophie Valkenburg, Malik Peiris, Wenwei Tu, Yu Lung Lau
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/e0161bcd3cb542a29c245989383f4cf8
Autor:
Daniel Leung, Carolyn A. Cohen, Xiaofeng Mu, Jaime S. Rosa Duque, Samuel M. S. Cheng, Xiwei Wang, Manni Wang, Wenyue Zhang, Yanmei Zhang, Issan Y. S. Tam, Jennifer H. Y. Lam, Sau Man Chan, Sara Chaothai, Kelvin K. H. Kwan, Karl C. K. Chan, John K. C. Li, Leo L. H. Luk, Leo C. H. Tsang, Nym Coco Chu, Wilfred H. S. Wong, Masashi Mori, Wing Hang Leung, Sophie Valkenburg, Malik Peiris, Wenwei Tu, Yu Lung Lau
Publikováno v:
SSRN Electronic Journal.
IntroductionTwo doses of inactivated SARS-CoV-2 vaccine CoronaVac cannot elicit high efficacy against symptomatic COVID-19, especially against the Omicron variant, but that can be improved by a third dose in adults. The use of a third dose of CoronaV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0b49e4413285826b4b4ef7ae550ff5a
https://doi.org/10.2139/ssrn.4115862
https://doi.org/10.2139/ssrn.4115862